Point72 Hong Kong LTD Cassava Sciences Inc Transaction History

Point72 Hong Kong LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $16,836 - $52,642	1,031 New	1,031 $43,000
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $121,663 - $197,982	-3,732 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $133,364 - $329,730	3,627 Added 3454.29%	3,732 $163,000
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $4,387 - $14,206	105 New	105 $7,000

195

13.7M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.